ScholarIQanswers from OpenAlex & ORCID
Kieran F. Docherty
ResearcherPublications, citations & collaboration network
Kieran F. Docherty is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kieran F. Docherty have?
ScholarIQindexed works
Kieran F. Docherty has 254 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kieran F. Docherty have?
ScholarIQcitation count
Kieran F. Docherty has 17,119 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kieran F. Docherty?
ScholarIQh-index
Kieran F. Docherty has an h-index of 47 in OpenAlex.
What is the i10-index of Kieran F. Docherty?
ScholarIQi10-index
Kieran F. Docherty has an i10-index of 115 in OpenAlex.
What is the ORCID of Kieran F. Docherty?
ScholarIQorcid
The ORCID for Kieran F. Docherty is on the source record.
What is the OpenAlex record for Kieran F. Docherty?
ScholarIQopenalex
The OpenAlex for Kieran F. Docherty is on the source record.
What are the most-cited papers on Kieran F. Docherty?
ScholarIQmost cited works
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Søren Lund Kristensen, Rasmus Rørth, Pardeep S. Jhund, Kieran F. Docherty, Naveed Sattar, David Preiss, Lars Køber, Mark C. Petrie, John J.V. McMurray
SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials
Muthiah Vaduganathan, Kieran F. Docherty, Brian Claggett, Pardeep S. Jhund, Rudolf A. de Boer, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, John J.V. McMurray, Scott D. Solomon
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
Mark C. Petrie, Subodh Verma, Kieran F. Docherty, Silvio E. Inzucchi, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andre Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon, Per Johanson, Peter J. Greasley, David W. Boulton, Olof Bengtsson, Pardeep S. Jhund, John J.V. McMurray
Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
Pardeep S. Jhund, Scott D. Solomon, Kieran F. Docherty, Hiddo J.L. Heerspink, Inder S. Anand, Michael Böhm, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Junbo Ge, Masafumi Kitakaze, Bela Merkley, Eileen O’Meara, Morten Shou, С. Н. Терещенко, Subodh Verma, Pham Nguyễn Vinh, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, John J.V. McMurray